UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia

Pharmaceuticals (Basel, Switzerland), 2022-03, Vol.15 (3), p.312

2022

Volltextzugriff (PDF)

Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial

PloS one, 2021-04, Vol.16 (4), p.e0247939-e0247939

2021

Volltextzugriff (PDF)

Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

Cardiovascular diabetology, 2022-04, Vol.21 (1), p.49-49, Article 49

2022

Volltextzugriff (PDF)

Combination of Insulin and Metformin in the Treatment of Type 2 Diabetes

Diabetes care, 2002-12, Vol.25 (12), p.2133-2140

2002

Volltextzugriff (PDF)

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

The New England journal of medicine, 2019-08, Vol.381 (9), p.841-851

2019

Volltextzugriff (PDF)

Treatment of Painful Diabetic Neuropathy Using Frequency Rhythmic Electro Magnetic Neural Stimulation

Diabetes, metabolic syndrome and obesity, 2023-05, Vol.16, p.1383

2023

Volltextzugriff (PDF)

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Diabetes care, 2018-09, Vol.41 (9), p.1938-1946

2018

Volltextzugriff (PDF)

Metformin and β‐cell function in insulin‐treated patients with type 2 diabetes: A randomized placebo‐controlled 4.3‐year trial

Diabetes, obesity & metabolism, 2018-03, Vol.20 (3), p.730-733

2018

Volltextzugriff (PDF)

Treatment of Painful Diabetic Neuropathy Using Frequency Rhythmic Electro Magnetic Neural Stimulation (FREMS); Effectiveness in Daily Practice

Diabetes, metabolic syndrome and obesity, 2023-01, Vol.16, p.1383-1391

2023

Volltextzugriff (PDF)

Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial

Journal of diabetes and its complications, 2018-02, Vol.32 (2), p.171-178

2018

Volltextzugriff (PDF)

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Diabetes, obesity & metabolism, 2019-04, Vol.21 (4), p.968-974

2019

Volltextzugriff (PDF)

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney international reports, 2022-01, Vol.7 (1), p.36-45

2022

Volltextzugriff (PDF)

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

Diabetes care, 2023-03, Vol.46 (3), p.593-601

2023

Volltextzugriff (PDF)

Continuation of metformin after introduction of insulin in type 2 diabetes

BMJ (Online), 2009-11, Vol.339 (7730), p.b4227

Kooy, Adriaan

International edition, 2009

Volltextzugriff (PDF)

Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

Diabetes, obesity & metabolism, 2023-08, Vol.25 (8), p.2413-2418

2023

Volltextzugriff (PDF)

21-OR: Optimization of Albuminuria Lowering Treatment by Crossover Rotation to Four Different Drug Classes

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

The Lancet (British edition), 2014-10, Vol.384 (9950), p.1265-1272

2014

Volltextzugriff (PDF)

Effect of metformin on arginine and dimethylarginines in patients with advanced type 2 diabetes: A post hoc analysis of a randomized trial

Diabetes, obesity & metabolism, 2022-10, Vol.24 (10), p.1983-1988

2022

Volltextzugriff (PDF)

Finerenone in Patients with CKD and T2D by SGLT-2i Treatment: An Analysis of the FIDELIO-DKD Study

The American heart journal, 2021-12, Vol.242, p.160-161

2021

Volltextzugriff (PDF)

Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58

Diabetes, obesity & metabolism, 2021-01, Vol.23 (1), p.29-38

2021

Volltextzugriff (PDF)

Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes

Diabetes, obesity & metabolism, 2023-11, Vol.25 (11), p.3152-3160

2023

Volltextzugriff (PDF)

Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.3064-3067

2023

Volltextzugriff (PDF)

A Gene Variant Near0 ATM Affects the Response to Metformin and Metformin Plasma Levels: A Post Hoc Analysis of an RCT

Pharmacogenomics, 2018-06, Vol.19 (8), p.715-726

2018

Volltextzugriff (PDF)

A gene variant near ATM affects the response to metformin and metformin plasma levels: a

Pharmacogenomics, 2018-05

2018

Volltextzugriff (PDF)

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

BMJ (Online), 2010-05, Vol.340, p.c2181

2010

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(54)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(33)
Diabetes
(30)
Humans
(25)
Diabetes Mellitus, Type 2 - Drug Therapy
(19)
Endocrinology & Metabolism
(18)
Insulin
(17)
Diabetes Mellitus
(16)
Female
(16)
Metformin
(16)
Male
(15)
Middle Aged
(15)
Aged
(12)
Antidiabetics
(11)
Cardiovascular Disease
(11)
Hypoglycemic Agents - Therapeutic Use
(11)
Clinical Trials
(10)
Adult
(9)
Biological And Medical Sciences
(9)
Diabetes Mellitus, Type 2 - Blood
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia

Metformin and N-terminal pro B-type natriuretic peptide in type 2 diabetes patients, a post-hoc analysis of a randomized controlled trial

Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

Combination of Insulin and Metformin in the Treatment of Type 2 Diabetes

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Treatment of Painful Diabetic Neuropathy Using Frequency Rhythmic Electro Magnetic Neural Stimulation

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Metformin and β‐cell function in insulin‐treated patients with type 2 diabetes: A randomized placebo‐controlled 4.3‐year trial

Treatment of Painful Diabetic Neuropathy Using Frequency Rhythmic Electro Magnetic Neural Stimulation (FREMS); Effectiveness in Daily Practice

Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial

How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

Continuation of metformin after introduction of insulin in type 2 diabetes

Effects of albuminuria‐lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

21-OR: Optimization of Albuminuria Lowering Treatment by Crossover Rotation to Four Different Drug Classes

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

Effect of metformin on arginine and dimethylarginines in patients with advanced type 2 diabetes: A post hoc analysis of a randomized trial

Finerenone in Patients with CKD and T2D by SGLT-2i Treatment: An Analysis of the FIDELIO-DKD Study

Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58

Overall and inter‐individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes

Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open‐label, crossover trial

A Gene Variant Near0 ATM Affects the Response to Metformin and Metformin Plasma Levels: A Post Hoc Analysis of an RCT

A gene variant near ATM affects the response to metformin and metformin plasma levels: a

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

Suchergebnisse filtern